Pharma Journalist -

Owkin and Sanofi have announced a new multi-year collaboration aimed at accelerating drug discovery and development through advanced artificial intelligence technologies. The agreement…
Read More...

Novo Nordisk has announced that its oral obesity treatment, Wegovy® (semaglutide) tablets 25 mg, has surpassed three million prescriptions in the United States within just over five…
Read More...

Alnylam Pharmaceuticals and Inceptive Nucleics have entered into a strategic collaboration valued at up to $2 billion aimed at accelerating the development of next-generation RNA-based…
Read More...

Lonza and Stipple Bio have entered into a multi-target licensing agreement aimed at accelerating the development of next-generation antibody-drug conjugate (ADC) therapies for cancer,…
Read More...

Biogen has received a significant regulatory boost for its investigational spinal muscular atrophy (SMA) therapy salanersen after the U.S. Food and Drug Administration (FDA) granted the…
Read More...

Chai Discovery has entered into a licensing agreement with pharmaceutical giant Pfizer, marking a significant step in the growing adoption of artificial intelligence technologies across…
Read More...

Cellares and TScan Therapeutics have entered into a strategic agreement to evaluate automated clinical manufacturing of TSC-101, an investigational T cell receptor-engineered T cell…
Read More...

Massive Bio and Optellum have announced a strategic collaboration designed to connect early lung cancer detection with faster access to clinical trials, potentially addressing one of…
Read More...

Roche has moved a step closer to bringing a potential new treatment option to patients with early-stage breast cancer after the U.S. Food and Drug Administration (FDA) accepted the…
Read More...

AbbVie has secured a significant regulatory milestone in Europe after the European Commission approved AQUIPTA® (atogepant) for the acute treatment of migraine in adults, providing…
Read More...